Assessment of Burden of Partial Response to Standard Doses of Proton Pump Inhibitors in Patients with Clinically Diagnosed Gastroesophageal Reflux Disease: A Real-World Evidence Study in India
A significant proportion of patients with GERD were partial responders to PPIs. Pantoprazole and rabeprazole had high patient adherence across disciplines. Both pantoprazole DDR 80 mg once daily (OD) and 40 mg BD demonstrated significant symptom reduction in partial responders, supporting their use in optimizing GERD management in Indian clinical settings.
Authors
- Amey Mane (ORCID: https://orcid.org/0000-0002-2902-4693)
- Sadhna Joglekar (ORCID: https://orcid.org/0000-0001-5739-4942)
- Rajiv Saikia
- Yogesh Garje
- Suyog Mehta (ORCID: https://orcid.org/0000-0001-7553-4128)
- Neeraj Markandeywar
- Sunil Gupta (ORCID: https://orcid.org/0000-0001-6810-6483)
- Ashwini Satpathy (ORCID: https://orcid.org/0000-0001-6425-6134)
- Chintan Khandhedia (ORCID: https://orcid.org/0009-0004-5632-7181)
- Shruti Dharmadhikari (ORCID: https://orcid.org/0000-0002-2249-2662)
- Praveen Sharma (ORCID: https://orcid.org/0000-0003-0954-463X)
- S.I. Perí
Institutions
- St. Augustine College (US)
- National Institute of Pathology (IN)
- Cipla (India) (IN)
- Sun Pharma (India) (IN)
- Sun Pharma Advanced Research (India) (IN)
- Malaviya National Institute of Technology Jaipur (IN)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1007/s40801-025-00497-8
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00